Company
Regulus Therapeutics Inc. (0001505512)
Standardized SEC financial data for Regulus Therapeutics Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001505512 · Pharmaceutical Preparations.
Revenue growth (YoY)
-100.0%
Return on equity
-60.7%
ROIC
-104.4%
Free cash flow
-$42.0M
Debt / equity
0.00×
Current ratio
10.98×
EPS (diluted)
$-0.82
Ratios for fiscal year 2021, standardized from SEC filings.
Income statement
| USD | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|
| Revenue | $6.8M | $10.0M | $0 | — | — | — |
| R&D expense |
Balance sheet
| USD | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $34.1M | $31.1M | $60.4M | $39.2M | $23.8M | $75.8M |
| Total current assets |
Cash flow
| USD | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$19.8M | -$12.5M | -$24.1M | -$25.5M | -$26.8M | -$41.7M |
| Capital expenditures |
Get 0001505512 data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/0001505512/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/0001505512/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"